Latest Milestone Payments News

El Dorado Goldfields has begun testing a 180km² Guyana land package after securing an option to acquire a 90% interest in the Oko North and Oko South projects. Early rock-chip assays reached 2.32 g/t gold, but the greenfields projects remain undrilled and have no defined resources or reserves.

American Tungsten & Antimony has completed its Nexus acquisition and secured ownership of the Del Sol hydrometallurgical refinery in Nevada, moving its US antimony strategy from transaction to execution. The Arizona White Spar acquisition remains conditional, while the completion consideration includes more than one billion shares and substantial performance rights.

LCL Resources has added a second Rio Tinto-funded exploration program in Papua New Guinea, while completing a 5,598 line-kilometre survey at its Ono project. The deal could see Rio Tinto earn up to 80% of Liamu, leaving LCL with funded exposure to several undrilled targets and A$7.76 million in cash.

xReality Group expanded its Operator XR customer base, recurring revenue and sales pipeline in the first quarter, while securing its first US Marine Corps order after quarter end. But the company remains focused on completing its FY26 audit and reinstating trading, with $1.4 million in quarter-end cash against $4.55 million of secured debt.

Moho Resources has confirmed two shallow, multi-lode gold systems at its Bush Chook project in Western Australia, but ended September with just $738,000 in cash and less than one quarter of funding at the quarter’s reported spending rate. The company is targeting broader exploration and follow-up drilling in 2027 while saying it expects to raise capital when required.

Hydrix reported September-quarter revenue growth of 11.6% year on year and secured further medical and Defence milestones. But with $1.5 million in cash and reported funding covering only 1.30 quarters, the company still needs contract wins to convert into receipts and revenue.

Firebird Metals has secured its first A$1 million ARENA payment and produced 99.999% manganese sulphate as work advances on its Perth demonstration plant. The next test is whether the company can reproduce those results with Oakover ore and move from pilot validation to customer-ready samples.

Liontown has set a quarterly record for underground development at Kathleen Valley while approving a $389 million expansion designed to lift steady-state concentrate production from FY30. The ramp-up is progressing, but lower plant feed, weaker recovery and higher unit costs show the transition is not yet frictionless.

Fluence has already exceeded its full-year 2025 EBITDA after nine months of 2026, but delayed customer decisions have cut order intake and pushed operating cash flow into the red. The ASX-listed water treatment group is betting on a stronger fourth quarter to convert its improving margins into cash and backlog.

Dimerix has more than doubled its cash balance after an Everest Medicines licensing payment and a drawdown from a secured funding facility. The ASX-listed biotech is also advancing its fully recruited Phase 3 trial while preparing a second kidney drug for Phase 2 testing.

Yari Resources has completed the Arcadia acquisition, lifting its combined reported Queensland coal resources to 504.9Mt and materially increasing its Indicated inventory. The enlarged portfolio brings product flexibility and infrastructure access, but also leaves Yari with technical work, contingent obligations and roughly two quarters of cash funding.

OncoSil Medical delivered sharper commercial growth and a string of regulatory milestones in FY26, but the oncology device company remains heavily loss-making and dependent on future sales or fresh capital. Revenue rose 44% to $1.68 million while operating cash outflow reached $10.47 million.